我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
210
53 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1990
进行中(未招募)
8
3.8%
已完成
107
51.0%
Enrolling By Invitation
3
1.4%
尚未招募
42
20.0%
招募中
31
14.8%
终止
4
1.9%
Unknown
2
0.9%
撤回
13
6.2%
暂无批准数据
- UT Southwestern researchers demonstrate promising results for magnetic seizure therapy (MST), a new depression treatment that uses magnetic pulses to trigger seizures, showing improved mental health outcomes. - The clinical trial reveals MST may offer significant advantages over traditional electroconvulsive therapy (ECT) by reducing cognitive side effects while maintaining therapeutic benefits. - This groundbreaking study brings the experimental treatment closer to potential FDA approval, offering new hope for patients with treatment-resistant depression.